Calculation of Filing Fee Tables
Form S-3
(Form Type)
Keros Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee(1) | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial effective date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward |
| Fees to Be Paid | Equity | Common Stock, $0.0001 par value per share | 457(o) and 457(r) | - | - | $250,000,000 | 0.00011020 | $27,550 | - | - | - | - |
| Fees Previously Paid | - | - | - | - | - | - | | - | | | | |
| Carry Forward Securities |
| Carry Forward Securities | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Offering Amounts | | $250,000,000 | | $27,550 | | | | |
| Total Fees Previously Paid | | | | - | | | | |
| Total Fee Offsets | | | | - | | | | |
| Net Fee Due | | | | $27,550 | | | | |
(1)Calculated in accordance with Rules 457(o) and 457(r) under the Securities Act of 1933, as amended (the “Securities Act”). In accordance with Rules 456(b) and 457(r) of the Securities Act, as amended, the registrant initially deferred payment of all of the registration fee for Registration Statement No. 333-255724 filed by the registrant on May 3, 2021.
